InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Colin John Meyer, Chief Innovation Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 7 open-market SEC Form 4 transactions: 0 purchases worth $0 and 7 sales worth $4.4M, reported from Mar 2, 23 to Aug 16, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 16, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 596 | $168.74 | $101K |
| Aug 15, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 2.1K | $169.07 | $362K |
| May 16, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 625 | $80.94 | $51K |
| May 15, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 4.5K | $85.77 | $379K |
| Mar 7, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 621 | $84.57 | $53K |
| Mar 3, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 5.3K | $87.35 | $462K |
| Mar 2, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 34.8K | $90.58 | $3.0M |